Prof. Saskia Middeldorp at the BSTH presenting High-Low and Alife-2. Practice changing! @MiddeldorpS
Peter Verhamme
@VerhammePeter
Trombose en Hemostase - UZ Leuven
135 Following 263 Followers 127 Posts
Latest posts 5
@MatthiasEngelen a game changer for patients with AHA
In a Belgian 🇧🇪 case series, emicizumab was successfully used for prevention of further bleeding in 7 patients w/ acquired #haemophilia A. Results of this study will be presented by @MatthiasEngelen at the #ISTH2023 congress 👨🏫 👉buff.ly/3Pdt2fV #FreeToRead ⏳View quoted post on X
Congrats to the team.
A milestone!
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial thelancet.com/journals/lance…View quoted post on X
More acquired hemophilia after COVID (vaccination) ?
In this case report, acquired #hemophilia A was diagnosed 10 days after #AstraZeneca #COVID19 vaccination in a man with autoimmune disease. The authors note that causality is uncertain, since AHA reports remain scarce despite billions of vaccinations.
bit.ly/3ycmlkHView quoted post on X
